Livzon Pharmaceutical Group: Senior executive Yang Liang resigns
Livzon Pharmaceutical Group Co., Ltd. (SZSE:000513) announced that its board of directors received a written resignation report from Vice President Yang Liang, effective March 31, 2025. Mr. Yang is resigning for personal development reasons and will no longer hold any position within the company or its subsidiaries. The company confirmed that Mr. Yang’s departure will not affect its normal operations. As of the date of the announcement, Mr. Yang holds 230,000 A shares of the company. Livzon's board expressed gratitude for Mr. Yang's dedication and contributions during his tenure as Vice President.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Livzon Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime